Latest Breaking News On - Andera partners - Page 1 : comparemela.com

First Irish patient implanted with innovative heart failure management system from Irish Company FIRE1

Dublin-based FIRE1 today announced that the first Irish patient has been successfully implanted with its FIRE1 System for remote heart failure monitoring. The innovative system has the potential to positively

Ireland
Merlin-park
Galway
Dublin
Irish
Conor-hanley
Faisal-sharif
Eileen-coen
Fergus-odea
Nicola-glynn
University-of-galway
Merlin-park-university-hospital

Grey Wolf Receives additional $50M in Series B Financing

Grey Wolf Receives additional $50M in Series B Financing
zenopa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zenopa.com Daily Mail and Mail on Sunday newspapers.

Grey-wolf-therapeutics
Pfizer-ventures
Andera-partners

Grey Wolf Therapeutics Closes Oversubscribed $50 Million Series B Financing Expansion, Led by ICG Life Sciences Team, to Accelerate and Expand First-of-its-Kind Antigen Modulation Technology

/PRNewswire/ Grey Wolf Therapeutics ("Grey Wolf" or "the company"), a clinical-stage biotechnology company leveraging first-of-its-kind antigen modulation.

United-states
London
City-of
United-kingdom
Australia
American
British
Catherine-armstrong
Peter-joyce
Tim-brons
Tracy-weightman
Oxford-science-enterprises

Grey Wolf Therapeutics Closes $50M Series B Financing Expansion

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United-kingdom
British
Peter-joyce
Life-sciences
Oxford-science-enterprises
Grey-wolf-therapeutics
United-kingdom-based
Pfizer-ventures
Andera-partners
Earlybird-venture-capital
British-patient

Grey Wolf Therapeutics Closes Oversubscribed $50 Million Series B Financing Expansion, Led by ICG Life Sciences, to Accelerate and Expand First-of-its-Kind Antigen Modulation Technology

United-kingdom
United-states
American
British
Peter-joyce
Tracy-weightman
American-society-of-clinical-oncology
Life-sciences
Oxford-science-enterprises
Brings-total-seriesb-funds-raised
Support-broadening-scope
Ongoing-clinical-trial